Meeting
2022 ASCO Quality Care Symposium
Defining key care events to integrate biomarker testing in the workup for patients with advanced non–small cell lung cancer (aNSCLC).
Authors
Nikki A. Martin
LUNGevity Foundation, Bethesda, MD
Nikki A. Martin, Latha Shivakumar, Leigh Boehmer, Ashley Lile, Stephanie A. Cohen, Amy Jo Pixley, Elana Plotkin, Julia R. Trosman, Christine B. Weldon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Quality Improvement Research and Implementation Science
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 346)
DOI
10.1200/JCO.2022.40.28_suppl.346
Abstract #
346
Poster Bd #
D19
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study.
First Author: Adam Gondos
Poster
2024 ASCO Breakthrough
Cost-effectiveness of liquid biopsy for molecular profiling of newly diagnosed advanced non-squamous NSCLC in an Asian population.
First Author: Aaron C. Tan
Poster
2023 ASCO Quality Care Symposium
Mutation-specific costs of advanced non-small cell lung cancer treatment.
First Author: Juanyi Tan
Poster
2023 ASCO Quality Care Symposium
Using real world practice patterns to identify clinical equipoise in cancer treatment: Advanced non-small cell lung cancer as an exemplar.
First Author: Yimeng Li